124 related articles for article (PubMed ID: 33476981)
21. Gfi-1 is the transcriptional repressor of SOCS1 in acute myeloid leukemia cells.
Lee MC; Kuo YY; Chou WC; Hou HA; Hsiao M; Tien HF
J Leukoc Biol; 2014 Jan; 95(1):105-15. PubMed ID: 24018353
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic alteration of the SOCS1 gene in hepatocellular carcinoma.
Chu PY; Yeh CM; Hsu NC; Chang YS; Chang JG; Yeh KT
Swiss Med Wkly; 2010; 140():w13065. PubMed ID: 20648401
[TBL] [Abstract][Full Text] [Related]
23. Effects of guluronic acid (G2013) on SHIP1, SOCS1 induction and related molecules in TLR4 signaling pathway.
Mortazavi-Jahromi SS; Farazmand A; Motamed N; Navabi SS; Mirshafiey A
Int Immunopharmacol; 2018 Feb; 55():323-329. PubMed ID: 29310108
[TBL] [Abstract][Full Text] [Related]
24. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas.
Li J; Bian EB; He XJ; Ma CC; Zong G; Wang HL; Zhao B
Int J Oncol; 2016 Feb; 48(2):723-33. PubMed ID: 26676363
[TBL] [Abstract][Full Text] [Related]
26. Suppressor of cytokine signaling 1 regulates embryonic myelopoiesis independently of its effects on T cell development.
O'Sullivan LA; Noor SM; Trengove MC; Lewis RS; Liongue C; Sprigg NS; Nicholson SE; Ward AC
J Immunol; 2011 Apr; 186(8):4751-61. PubMed ID: 21421851
[TBL] [Abstract][Full Text] [Related]
27. JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI.
Li LL; Xue AM; Li BX; Shen YW; Li YH; Luo CL; Zhang MC; Jiang JQ; Xu ZD; Xie JH; Zhao ZQ
Breast Cancer Res; 2014 May; 16(3):R56. PubMed ID: 24886710
[TBL] [Abstract][Full Text] [Related]
28. p53 inactivation upregulates p73 expression through E2F-1 mediated transcription.
Tophkhane C; Yang SH; Jiang Y; Ma Z; Subramaniam D; Anant S; Yogosawa S; Sakai T; Liu WG; Edgerton S; Thor A; Yang X
PLoS One; 2012; 7(8):e43564. PubMed ID: 22952705
[TBL] [Abstract][Full Text] [Related]
29. Association between methylation of tumor suppressor gene SOCS1 and acute myeloid leukemia.
Zhang XH; Yang L; Liu XJ; Zhan Y; Pan YX; Wang XZ; Luo JM
Oncol Rep; 2018 Aug; 40(2):1008-1016. PubMed ID: 29916533
[TBL] [Abstract][Full Text] [Related]
30. SOCS1 hypermethylation mediated by DNMT1 is associated with lipopolysaccharide-induced inflammatory cytokines in macrophages.
Cheng C; Huang C; Ma TT; Bian EB; He Y; Zhang L; Li J
Toxicol Lett; 2014 Mar; 225(3):488-97. PubMed ID: 24440346
[TBL] [Abstract][Full Text] [Related]
31. REX1 promotes EMT-induced cell metastasis by activating the JAK2/STAT3-signaling pathway by targeting SOCS1 in cervical cancer.
Zeng YT; Liu XF; Yang WT; Zheng PS
Oncogene; 2019 Oct; 38(43):6940-6957. PubMed ID: 31409905
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional regulation of thymine DNA glycosylase (TDG) by the tumor suppressor protein p53.
da Costa NM; Hautefeuille A; Cros MP; Melendez ME; Waters T; Swann P; Hainaut P; Pinto LF
Cell Cycle; 2012 Dec; 11(24):4570-8. PubMed ID: 23165212
[TBL] [Abstract][Full Text] [Related]
33. SOCS1 counteracts ROS-mediated survival signals and promotes apoptosis by modulating cell cycle to increase radiosensitivity of colorectal cancer cells.
Ryu JY; Oh J; Kim SM; Kim WG; Jeong H; Ahn SA; Kim SH; Jang JY; Yoo BC; Kim CW; Lee CE
BMB Rep; 2022 Apr; 55(4):198-203. PubMed ID: 35321782
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional repression of Aurora-A gene by wild-type p53 through directly binding to its promoter with histone deacetylase 1 and mSin3a.
Yang TY; Teng CJ; Lin TC; Chen KC; Hsu SL; Wu CC
Int J Cancer; 2018 Jan; 142(1):92-108. PubMed ID: 28884479
[TBL] [Abstract][Full Text] [Related]
35. Dendritic cells with increased expression of suppressor of cytokine signaling 1(SOCS1) gene ameliorate lipopolysaccharide/d-galactosamine-induced acute liver failure.
Li SS; Yang M; Chen YP; Tang XY; Zhang SG; Ni SL; Yang NB; Lu MQ
Mol Immunol; 2018 Sep; 101():10-18. PubMed ID: 29852455
[TBL] [Abstract][Full Text] [Related]
36. Anti-inflammatory mechanisms of suppressors of cytokine signaling target ROS via NRF-2/thioredoxin induction and inflammasome activation in macrophages.
Kim GY; Jeong H; Yoon HY; Yoo HM; Lee JY; Park SH; Lee CE
BMB Rep; 2020 Dec; 53(12):640-645. PubMed ID: 33172542
[TBL] [Abstract][Full Text] [Related]
37. Pure curcumin increases the expression of SOCS1 and SOCS3 in myeloproliferative neoplasms through suppressing class I histone deacetylases.
Chen CQ; Yu K; Yan QX; Xing CY; Chen Y; Yan Z; Shi YF; Zhao KW; Gao SM
Carcinogenesis; 2013 Jul; 34(7):1442-9. PubMed ID: 23430957
[TBL] [Abstract][Full Text] [Related]
38. TLR4 signaling and the inhibition of liver hepcidin expression by alcohol.
Zmijewski E; Lu S; Harrison-Findik DD
World J Gastroenterol; 2014 Sep; 20(34):12161-70. PubMed ID: 25232250
[TBL] [Abstract][Full Text] [Related]
39. p53 negatively regulates Aurora A via both transcriptional and posttranslational regulation.
Wu CC; Yang TY; Yu CT; Phan L; Ivan C; Sood AK; Hsu SL; Lee MH
Cell Cycle; 2012 Sep; 11(18):3433-42. PubMed ID: 22894933
[TBL] [Abstract][Full Text] [Related]
40. SOCS1 links cytokine signaling to p53 and senescence.
Calabrese V; Mallette FA; Deschênes-Simard X; Ramanathan S; Gagnon J; Moores A; Ilangumaran S; Ferbeyre G
Mol Cell; 2009 Dec; 36(5):754-67. PubMed ID: 20005840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
